On ECHEMI
Home > Drugs > diabetes
diabetes
Diabetes is a common disease caused by the interaction of genetic and environmental factors. The main clinical sign is high blood sugar. Common symptoms include polydipsia, polyuria, polyphagia, and weight loss. Diabetes can cause damage to multiple systems in the body, leading to absolute or relative insulin deficiency and reduced insulin sensitivity of target tissue cells, causing a series of metabolic disorders such as protein, fat, water, and electrolytes. Significant increase in blood sugar can cause acute complications such as diabetic ketoacidosis and hyperosmolar coma. Long-term illness can also cause vascular and neuropathy, resulting in damage to multiple organs and tissues such as the heart, brain, kidneys, eyes, nerves, and skin, affecting the patient's quality of life and even shortening life expectancy. Active prevention and treatment should be carried out.
Related Drugs
Pioglitazone hydrochloride
Indication: This product can be used as an adjunctive treatment for patients with type 2 diabetes who use diet and exercise to improve blood sugar. This product can be used alone; when diet and pioglitazone alone cannot satisfactorily control blood sugar, it can be used in combination with sulfonylureas, metformin or insulin.
Pioglitazone hydrochloride
Indication: This product can be used as an adjunctive treatment for patients with type 2 diabetes who use diet and exercise to improve blood sugar. This product can be used alone; when diet and pioglitazone alone cannot satisfactorily control blood sugar, it can be used in combination with sulfonylureas, metformin or insulin.
Manufacturer:

Jiangsu Tasly DIYI Pharmaceutical Co., Ltd.

Pioglitazone hydrochloride
Indication: This product can be used as an adjunctive treatment for patients with type 2 diabetes who use diet and exercise to improve blood sugar. This product can be used alone; when diet and pioglitazone alone cannot satisfactorily control blood sugar, it can be used in combination with sulfonylureas, metformin or insulin.
Manufacturer:

Zhejiang Jinhua Conba BIO-PHARM. Co., Ltd.

Pioglitazone hydrochloride
Indication: This product can be used as an adjunctive treatment for patients with type 2 diabetes who use diet and exercise to improve blood sugar. This product can be used alone; when diet and pioglitazone alone cannot satisfactorily control blood sugar, it can be used in combination with sulfonylureas, metformin or insulin.
Lipoic Acid Capsules
Indication: Treatment of diabetic peripheral neuropathy.
Manufacturer:

Penglai Nuokang Pharmaceutical Co., Ltd.

Lipoic Acid Injection
Indication: Paresthesias due to diabetic peripheral neuropathy
Manufacturer:

Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd.

Gliclazide Tablets
Indication: Used for type 2 diabetes.
Manufacturer:

Yabao Pharmaceutical Group Co., Ltd.

Gliclazide Tablets
Indication: Used for type 2 diabetes.
Gliclazide Tablets
Indication: Used for type 2 diabetes.
Manufacturer:

Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY

Puerarin Injection
Indication: It can be used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, sudden deafness and ischemic cerebrovascular disease, viral myocarditis in children, diabetes, etc.
Manufacturer:

Zhejiang Conba Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.